Key facts
- Uute Scientific’s last known valuation is $11.3M (Jan 2022).
- It has raised $5.7M; the latest was Later Stage VC ($2.1M) in Mar 2025.
- Notable investors include Tesi, University of Helsinki Endowment, Butterfly Ventures, Health Incubator Helsinki, Kiuas Accelerator — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Uute Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Uute Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uute Scientific
Producer of health and wellness ingredients intended to eliminate immune-mediated diseases such as diabetes and allergies. The company's ingredients include extracts made from natural substances with diverse microbes from forests and agricultural environments to be used as an ingredient in ordinary consumer goods, enabling patients to develop immune systems and decrease the probability of getting such diseases.
- Sector
- Healthcare
- HQ
- Helsinki, Finland
- Founded
- 2019
- Employees
- 9
- Website
- uutescientific.com/
- Ownership
- Privately Held (backing)
Uute Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uute Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uute Scientific in its N-PORT filings yet. We sweep new filings monthly.